Buy Day today: Neutral (58) Mixed market breadth · no major macro event

Labcorp Holdings Inc.

Healthcare · Diagnostics & Research

308.70$ +0.1% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Income Statement

Labcorp Holdings Inc. (LH) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 3,731 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement LH
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	2,415	2,428	2,447	2,543	2,655	2,796	2,848	2,866	2,831	2,788	2,791	2,882	2,929	2,953	2,824	2,769	3,896	4,490	4,162	3,841	4,063	4,056	3,900	2,923	2,867	3,674	3,038	3,034	3,057	3,033	3,177	3,221	3,282	3,329	3,345	3,527	3,564	3,516	3,538	3,731	14,348
Cost of Revenue	1,626	1,640	1,643	1,681	1,772	1,881	2,069	2,031	2,041	2,015	2,002	2,057	2,111	2,133	2,096	2,008	2,337	2,585	2,563	2,576	2,677	2,681	2,667	1,981	1,981	2,704	2,188	2,192	2,206	2,212	2,279	2,295	2,378	2,433	2,397	2,481	2,538	2,595	2,599	2,619	10,352
Gross Profit	788	788	804	862	883	916	779	835	790	772	790	825	817	821	728	761	1,559	1,905	1,599	1,265	1,386	1,375	1,233	943	886	970	850	842	851	821	897	926	904	896	948	1,046	1,025	921	938	1,112	3,996
Research & Development	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	2.0	–	–	–	–	–	–	–	–	–	–	–
Selling, General & Administrative	401	406	419	435	465	492	397	395	382	397	394	415	402	414	396	396	420	1,729	429	459	520	544	464	486	510	537	554	506	526	533	508	558	569	595	546	579	552	539	551	577	2,219
Total Operating Expenses	442	455	467	487	520	555	459	454	437	453	451	476	463	478	921	463	512	609	541	561	619	644	545	514	512	879	520	576	599	944	576	632	650	680	622	652	629	539	551	660	2,379
Operating Income	324	323	333	336	341	354	305	369	343	308	318	336	340	336	-193	298	1,047	1,293	1,058	704	767	731	688	429	374	91	330	266	252	-123	321	295	254	217	326	395	397	382	387	452	1,617
Interest Expense	58	53	52	55	60	68	64	63	59	58	57	59	61	64	55	53	51	48	49	78	42	43	42	43	46	49	51	50	50	49	47	48	50	63	56	57	56	55	55	61	227
Pre-Tax Income	263	277	280	285	281	289	242	313	500	215	255	270	287	293	-268	297	947	1,243	1,022	651	768	686	640	360	316	45	272	205	239	-147	297	268	211	184	275	305	337	191	320	386	1,234
Income Tax Expense	84	92	87	96	98	-420	69	79	109	56	69	79	66	66	49	65	243	304	252	183	180	132	148	92	38	-32	64	50	55	20	69	62	41	40	62	66	76	26	42	87	230
Net Income	180	184	192	189	181	707	173	234	391	158	186	190	221	227	-317	232	703	938	770	467	587	553	492	359	353	76	213	189	183	-167	228	205	169	143	213	238	261	165	278	299	1,002
EBITDA	484	454	457	507	460	502	485	543	495	410	512	539	502	513	-68	451	1,151	1,475	1,303	964	1,046	967	893	514	496	250	465	411	478	295	499	472	423	418	498	532	564	419	548	621	2,152

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings